Advanced search×

[Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].

Vopr Onkol 56(5):571-5 (2010) PMID 21137237

Basic hematological features of CEA/ABVD medication for Hodgkin's disease were studied. An effective model was worked out on the principle of data discrimination for predicting different leukocytic toxicities induced by cytostatics-1 administration, once in two weeks. It might predict individual limits (dosage and intervals) of a chemotherapy course unless a colony-stimulation technique is used.

Version: za2963e q8za6 q8zb1 q8zc2 q8zd0 q8ze0 q8zf2 q8zg2

Similar articles you may find interesting…

  1. Characteristics of Children with Non-Hodgkin Lymphoma Associated with Primary Immune Deficiency Diseases: Descriptions of Five Patients.

    Pediatr Hematol Oncol (2013) PMID 23647505

    All patients were male (median age, 8 years). Stage distribution was stage III in three patients and stage IV in two patients. Three patients had B-cell lymphoma and two had T-cell lymphoma. Reduced doses of Berlin-Frankfurt-Münster (BFM) and French Society of Pediatric Oncology (SFOP) regimens we...
  2. Performance of the Framingham Risk Score in Patients Receiving Hemodialysis.

    Nephrology (Carlton) (2013) PMID 23647978

    The mean follow-up period was 4.4 ± 1.5 years. Intermediate risk predicted overall hazard ratio (HR) (2.157, P = 0.039) and cardiovascular mortality (HR= 5.023; P = 0.004) versus low risk, but "high" risk did not. High risk (versus low risk) predicted cardiovascular events (HR = 2.458, P = 0.05). B...
  3. The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.

    Mol Biol Rep (2013) PMID 23649760

    The Cdx-2 polymorphism in VDR gene has been extensively investigated for association with cancer risk, however, results of different studies have been inconsistent. The objective of this study is to assess the relationship of the Cdx-2 polymorphism in VDR and cancer risk by meta-anal...